FAF
MRNA icon

Första AP-fonden’s Moderna MRNA Stock Holding History

Första AP-fonden’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-64,700
Closed -$1.83M – 566
2025
Q1 		$1.83M Sell
64,700
-4,700
-7% -$167K 0.01% 541
2024
Q4 		$2.89M Buy
69,400
+500
+0.7% +$23.9K 0.02% 511
2024
Q3 		$4.6M Buy
68,900
+8,400
+14% +$771K 0.04% 414
2024
Q2 		$7.18M Sell
60,500
-6,100
-9% -$772K 0.06% 291
2024
Q1 		$7.1M Buy
66,600
+7,000
+12% +$706K 0.06% 311
2023
Q4 		$5.93M Sell
59,600
-3,100
-5% -$261K 0.06% 312
2023
Q3 		$6.48M Buy
62,700
+300
+0.5% +$33.5K 0.07% 278
2023
Q2 		$7.58M Buy
62,400
+300
+0.5% +$40K 0.08% 262
2023
Q1 		$9.54M Sell
62,100
-54,000
-47% -$8.91M 0.11% 199
2022
Q4 		$20.9M Buy
116,100
+24,600
+27% +$4.02M 0.24% 89
2022
Q3 		$10.8M Buy
91,500
+30,400
+50% +$4.61M 0.13% 161
2022
Q2 		$8.73M Sell
61,100
-21,800
-26% -$3.12M 0.11% 195
2022
Q1 		$14.3M Buy
82,900
+800
+1% +$135K 0.16% 131
2021
Q4 		$20.9M Buy
82,100
+5,100
+7% +$1.49M 0.21% 93
2021
Q3 		$29.6M Buy
77,000
+700
+0.9% +$258K 0.34% 60
2021
Q2 		$17.9M Buy
76,300
+21,300
+39% +$3.81M 0.21% 95
2021
Q1 		$7.2M Buy
55,000
+5,500
+11% +$797K 0.1% 235
2020
Q4 		$5.17M Sell
49,500
-4,900
-9% -$496K 0.08% 308
2020
Q3 		$3.85M Buy
54,400
+17,100
+46% +$1.19M 0.08% 286
2020
Q2 		$2.4M Buy
+37,300
New +$2.04M 0.06% 329

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Första AP-fonden's MRNA Position: Q2 2025 in Review

Första AP-fonden sold out of Moderna (MRNA) in Q2 2025, closing a stake of 64,700 shares — an estimated $1.83M sold.

Första AP-fonden first reported a position in MRNA in Q2 2020 and held it in 20 quarters. The position peaked at $29.6M in Q3 2021. 674 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • Första AP-fonden reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • Första AP-fonden sold 64,700 Moderna shares in Q2 2025, an estimated $1.83M.
  • Första AP-fonden first reported a position in Moderna in Q2 2020 and held it in 20 quarters.
  • Första AP-fonden's Moderna position peaked at $29.6M in Q3 2021.
  • 674 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on Första AP-fonden's 13F filing for Q2 2025, filed 8 Aug 2025.